Table 2.
Meta-analysis of inflammation markers and risk of CVD.
| Biomarker | Pooled results (95% CI) | Signifificance test (P-value) | No. of studies | No. of effffect estimates | P-value for Heterogeneity | I 2 |
|---|---|---|---|---|---|---|
| FIB | OR: 1.21 (1.15–1.27) | <0.001 | 4 | 7 | 0.117 | 41.1% |
| HR: 1.04 (1.00–1.07) | 0.029 | 5 | 7 | 0.087 | 45.8% | |
| IL-6 | HR: 1.16 (1.10–1.22) | <0.001 | 8 | 8 | 0.483 | 0.0% |
| CRP | OR: 1.25 (1.15–1.35) | <0.001 | 3 | 6 | 0.082 | 48.8% |
| HR: 1.20 (1.14–1.25) | <0.001 | 16 | 28 | <0.001 | 65.8% | |
| Gal-3 | HR: 1.09 (1.05–1.14) | <0.001 | 7 | 12 | 0.375 | 7.2% |